Suchergebnisse - "Nogami, Asako"

PubPharm (62)

1

Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction-associated steatotic liver disease

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Song, S. | Nogami, A. | Liang, L. | +8

2

Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis

enthalten in: Expert opinion on emerging drugs | 2024

von Iwaki, M. | Yoneda, M. | Wada, N. | +5

3

Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis

enthalten in: Tomography (Ann Arbor, Mich.) | 2024

von Koyama, S. | Nogami, A. | Yoneda, M. | +8

4

Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography

enthalten in: Journal of gastroenterology | 2024

von Kobayashi, T. | Iwaki, M. | Nogami, A. | +7

5

Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction‐associated steatotic liver disease

enthalten in: Liver International | 2024

von Song, S. | Nogami, A. | Liang, L. | +8

6

Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care

enthalten in: Gut and liver | 2023

von Yoneda, M. | Kobayashi, T. | Iwaki, M. | +3

7

Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease

enthalten in: Hepatology communications | 2023

von Iwaki, M. | Kessoku, T. | Tanaka, K. | +13

8

Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease : A Review

enthalten in: Life (Basel, Switzerland) | 2023

von Nagai, K. | Nagai, K. | Iwaki, M. | +5

9

Epidemiology and Management of Drug-induced Liver Injury : Importance of the Updated RUCAM

enthalten in: Journal of clinical and translational hepatology | 2023

von Kobayashi, T. | Iwaki, M. | Nogami, A. | +1

10

Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography

enthalten in: Journal of gastroenterology | 2023

von Kobayashi, T. | Iwaki, M. | Nogami, A. | +7

1
2
3
4
5
6
7
Nächster »
[7]